Seranovo

Developer of molecules and protein degraders for drug absorption

placeLeiden, South Holland, Netherlands calendar_todayFounded 2017 groups12 employees language seranovo.com

Social engagement

Social engagement: 3.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%

Recent activity

2 Jul 2026
Event
Life Sciences Café XL x Meet & Mingle
1 Jul 2026
Event
From the past to the future of oral drug formulations
25 Jun 2026
Product launch
NanoGlass ExpoSureTM Program
Coming soon